Defining metabolic activity of nephrolithiasis - Appropriate evaluation and follow-up of stone formers

Defining metabolic activity of nephrolithiasis - Appropriate evaluation and follow-up of stone formers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.AJUR.2018.06.007
P932PMC publication ID6197397
P698PubMed publication ID30364613

P50authorIta Pfeferman HeilbergQ67189767
P2093author name stringGiovanni Gambaro
Glenn M Preminger
Pietro Manuel Ferraro
Daniel A Wollin
Antonio Nouvenne
Adam G Kaplan
Andrea Tasca
Emanuele Croppi
P2860cites workMedical management of kidney stones: AUA guidelineQ28240681
When is medical prophylaxis cost-effective for recurrent calcium stones?Q30843922
Adequacy of a single stone risk analysis in the medical evaluation of urolithiasisQ31931080
Metabolic evaluation of first-time and recurrent stone formersQ33737379
Expression of fibroblast growth factor 23, vitamin D receptor, and sclerostin in bone tissue from hypercalciuric stone formers.Q33835734
Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of PhysiciansQ34445981
The ROKS nomogram for predicting a second symptomatic stone episodeQ34568756
Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formationQ34657936
A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stonesQ34730506
Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective studyQ34732675
Dietary calcium from dairy and nondairy sources, and risk of symptomatic kidney stonesQ35373518
Nephrolithiasis: why doesn't our "learning" progress?Q35744855
Variations between two 24-hour urine collections in patients presenting to a tertiary stone clinicQ35788301
Adverse metabolic side effects of thiazides: implications for patients with calcium nephrolithiasisQ36768914
RANKL is a mediator of bone resorption in idiopathic hypercalciuria.Q36843360
Evaluation of the recurrent stone formerQ36902341
Asymptomatic nephrolithiasis detected by ultrasoundQ37123160
Evidence for durable kidney stone prevention over several decadesQ37401624
Bone disease in patients with primary hypercalciuria and calcium nephrolithiasisQ37475818
Abnormalities of 24-hour urine composition in first-time and recurrent stone-formersQ38037888
Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA technology assessmentQ38053773
Optimum nutrition for kidney stone diseaseQ38084518
Digital Tomosynthesis: A Viable Alternative to Noncontrast Computed Tomography for the Follow-Up of Nephrolithiasis?Q38808284
Digital tomosynthesis in the detection of urolithiasis: Diagnostic performance and dosimetry compared with digital radiography with MDCT as the reference standard.Q39938570
Adequacy of a single 24-hour urine collection for metabolic evaluation of recurrent nephrolithiasisQ42966934
A nomogram for the prediction of kidney stone recurrenceQ43030405
Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasisQ43589877
Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidismQ43619329
Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuriaQ43850214
Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventionsQ44288956
Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practiceQ44686649
An individualized weight-based goal urine volume model significantly improves expected calcium concentrations relative to a 2-L goal urine volumeQ45841973
Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination SurveyQ48662799
Progression of nephrolithiasis: long-term outcomes with observation of asymptomatic calculi.Q50748162
Fracture risk among patients with urolithiasis: a population-based cohort study.Q50908960
Natural history of asymptomatic renal stones and prediction of stone related events.Q51292398
Should patients with single renal stone occurrence undergo diagnostic evaluation?Q51650964
A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis.Q53672108
How physician and patient perceptions differ regarding medical management of stone disease.Q54328061
Medical reduction of stone risk in a network of treatment centers compared to a research clinicQ58118326
Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective studyQ70279032
Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patientsQ70303959
Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsyQ72820917
A prospective study of nonmedical prophylaxis after a first kidney stoneQ78196175
Effect of medical management on recurrent stone formation following percutaneous nephrolithotomyQ80166446
24-hour urine collection in the metabolic evaluation of stone formers: is one study adequate?Q84960641
Prevalence of 24-hour urine collection in high risk stone formersQ85705663
Beyond belief--how people feel about taking medications for heart diseaseQ86487017
P433issue4
P407language of work or nameEnglishQ1860
P1104number of pages8
P304page(s)235-242
P577publication date2018-10-01
P1433published inAsian Journal of UrologyQ50807185
P1476titleDefining metabolic activity of nephrolithiasis - Appropriate evaluation and follow-up of stone formers
P478volume5

Reverse relations

Q90393771Calcium Kidney Stones are Associated with Increased Risk of Carotid Atherosclerosis: The Link between Urinary Stone Risks, Carotid Intima-Media Thickness, and Oxidative Stress Markerscites workP2860

Search more.